See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing ...

Summary by Hastings Tribune
Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investors

5 Articles

All
Left
Center
3
Right
Hastings TribuneHastings Tribune
Center

Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing ...

Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investors

Read Full Article
STATSTAT
Center

CRISPR company Arbor Biotechnologies gets cash infusion from ARCH

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a lifeline to head to clinical trials.

·Boston, United States
Read Full Article
The Business JournalsThe Business Journals
Center

Feng Zhang gene-editing spinout closes $74M funding

The Cambridge biotech announced on Tuesday it closed a $73.9 million funding round led by Arch Venture Partners and TCGX.

·United States
Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

Arbor to advance gene editing treatments with $73.9m funding

Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system diseases.

Read Full Article
Endpoints NewsEndpoints News

CRISPR company Arbor raises $73.9M to test therapy in clinical trials

Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years ago, has closed a $73.9 million Series C financing to bring its first therapy into clinical trials — a treatment that could help prevent ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Business Journals broke the news in United States on Tuesday, March 18, 2025.
Sources are mostly out of (0)

Similar News Topics

Business

Business

Gene Editing

Gene Editing

CRISPR

CRISPR

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal